Macquarie Group’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-315
Closed -$9K 2073
2024
Q1
$9K Sell
315
-1,267
-80% -$36.2K ﹤0.01% 1595
2023
Q4
$44K Sell
1,582
-1,730,710
-100% -$48.1M ﹤0.01% 1590
2023
Q3
$38.8M Sell
1,732,292
-219,161
-11% -$4.91M 0.05% 477
2023
Q2
$79.4M Buy
1,951,453
+308,303
+19% +$12.5M 0.09% 289
2023
Q1
$79.6M Buy
1,643,150
+76,470
+5% +$3.7M 0.09% 287
2022
Q4
$59.8M Buy
1,566,680
+4,462
+0.3% +$170K 0.07% 380
2022
Q3
$78.5M Sell
1,562,218
-126,516
-7% -$6.35M 0.1% 285
2022
Q2
$67.7M Buy
1,688,734
+135,806
+9% +$5.44M 0.08% 360
2022
Q1
$57.9K Buy
1,552,928
+30,101
+2% +$1.12K 0.04% 477
2021
Q4
$60.7M Sell
1,522,827
-48,614
-3% -$1.94M 0.05% 453
2021
Q3
$58.5M Buy
1,571,441
+315,825
+25% +$11.8M 0.05% 474
2021
Q2
$53.1M Buy
1,255,616
+106,835
+9% +$4.52M 0.04% 515
2021
Q1
$54.4M Buy
1,148,781
+99,374
+9% +$4.71M 0.08% 315
2020
Q4
$64M Buy
1,049,407
+97,229
+10% +$5.93M 0.09% 256
2020
Q3
$44.5M Buy
952,178
+18,240
+2% +$853K 0.08% 296
2020
Q2
$47.4M Buy
933,938
+132,241
+16% +$6.71M 0.08% 266
2020
Q1
$35.8M Buy
801,697
+395,128
+97% +$17.6M 0.07% 283
2019
Q4
$19.5M Buy
+406,569
New +$19.5M 0.03% 522
2018
Q3
Sell
-200
Closed -$7K 2241
2018
Q2
$7K Buy
+200
New +$7K ﹤0.01% 2138
2018
Q1
Sell
-600
Closed -$10K 2328
2017
Q4
$10K Sell
600
-4,500
-88% -$75K ﹤0.01% 2262
2017
Q3
$102K Buy
+5,100
New +$102K ﹤0.01% 1912
2016
Q2
Sell
-40,643
Closed -$262K 1628
2016
Q1
$262K Buy
40,643
+933
+2% +$6.01K ﹤0.01% 1322
2015
Q4
$1.29M Sell
39,710
-1,885
-5% -$61.1K ﹤0.01% 1032
2015
Q3
$1.11M Buy
41,595
+1,927
+5% +$51.5K ﹤0.01% 1113
2015
Q2
$1.91M Buy
39,668
+3,292
+9% +$158K ﹤0.01% 1036
2015
Q1
$2.21M Sell
36,376
-6,550
-15% -$398K ﹤0.01% 988
2014
Q4
$2.22M Buy
42,926
+9,307
+28% +$482K ﹤0.01% 988
2014
Q3
$1.48M Buy
+33,619
New +$1.48M ﹤0.01% 1078